]>
IRCT20210725051986N1 IRCT 2021-11-03 Yazd University of Medical Sciences Effect of cannulation in scarred and non-scarred areas on pain intensity and bleeding in hemodialysis patients The effect of fistula cannulation in scarred and non-scarred areas on pain intensity and bleeding in hemodialysis patients 2021-10-23 anticipated 74 Complete https://irct.ir/trial/57935 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Crossover, Purpose: Supportive, Randomization description: The available sample (74 patients) is selected based on the inclusion criteria and after extracting the patients' names and referring to the project statistical consultant, they are assigned a three-digit code 001 to 074. Using Random allocation statistical software by simple randomization method and sequence 001 to 074 in a row, the samples are divided into two groups A and B. In group A, first cannulation is performed at the scar site and in group B, first non-scar cannulation is performed and in the next stage, the interventions are shifted. N/A Hemodialysis. Intervention 1: Intervention group: 74 patients are cross-selected for intervention based on inclusion criteria. After extracting, the patients' names were coded and they were placed in one of the two study groups using random allocation software. Intravenous arterial needle No. 20 hemodialysis made by the company Medwayteb and is placed in the fistula at least from a distance of 5 cm from the fistula with an angle of 30 to 40 degrees while the diagonal part of the needle is high. This is done in the first session according to the random allocation to determine the priority in terms of placement in the scar or non-scar fistula and in the next session vice versa for each patient. Intervention 2: Control group: The same interventions of the intervention group are performed. Yes - There is a plan to make this available What will be shared: Information will be published without the names of participants and hospitals. Confidentiality of personal information will be assured When: After the publication of the results and the final defense of the dissertation To whom: Supervisor, members of the faculty / university research committee Conditions: Improving patient conditions and use for evidence-based care Where to obtain: Dr. Mostafa Javadi How to obtain: Written request from the researcher or scientific organizations and the university Comments:
public Taybeh Dehghani firoozabadi
Shahid Naser Zarei Aly., Shahid Mirbagheri Str.
Meybod Iran (Islamic Republic of) 8961817955 +98 35 3824 1751 Tay.dehghani@gmail.com Yazd University of Medical Sciences scientific Dr. Mostafa Javadi
Sadoughi School of Nursing and Midwifery, in front of Infertility Center, Safaieh St., Bouali Blvd.
Yazd Iran (Islamic Republic of) 8916877443 +98 35 3824 1751 javadinurse@gmail.com Yazd University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) Iran (Islamic Republic of) Iran (Islamic Republic of) At least 3 months of history of hemodialysis through fistula Alertness Age over 18 years No difficulty in accessing blood vessels Lack of neuropathy and patients with peripheral vascular injuries 18 years 70 years Both Malignancy and severe infection Patients with skin diseases in or around the fistula Patients who need surgery due to fistula dysfunction Z49.0 Preparatory care for renal dialysis Other N/A Intervention group: 74 patients are cross-selected for intervention based on inclusion criteria. After extracting, the patients' names were coded and they were placed in one of the two study groups using random allocation software. Intravenous arterial needle No. 20 hemodialysis made by the company Medwayteb and is placed in the fistula at least from a distance of 5 cm from the fistula with an angle of 30 to 40 degrees while the diagonal part of the needle is high. This is done in the first session according to the random allocation to determine the priority in terms of placement in the scar or non-scar fistula and in the next session vice versa for each patient. Control group: The same interventions of the intervention group are performed. The average pain score on the visual analogue scale. Timepoint: After insertion of the needle into the fistula in both methods studied. Method of measurement: Visual Analogue Scale. The amount of bleeding after the needle is removed from the fistula. Timepoint: After removal of the needle from the fistula in both methods studied. Method of measurement: Standard Future model scales with a sensitivity of 0.01 g. Patient preference for using the cannulation method. Timepoint: After interventions. Method of measurement: ًuestionnaire. Yazd University of Medical Sciences Approved 2020-09-08 Research Ethics Committee of Shahid Sadoughi University of Medical Sciences Central Administration, Bahonar Sq., Yazd Yazd Yazd Iran (Islamic Republic of)